Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-061319

Chief Scientific Officer sold 11,200 shares at an average $33.71 ($377,561)

  • Chief Scientific Officer acquired 11,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-19 Exercise or conversion : show line 1 in the form +3,800 $6.55 $24,890 73,160 D
2021-10-19 Sale : show line 2 in the form −300 $32.91 $9,873 72,860 D
2021-10-19 Sale : show line 3 in the form −3,500 $33.76 $118,160 69,360 D
2021-10-20 Exercise or conversion : show line 4 in the form +3,700 $6.55 $24,235 73,060 D
2021-10-20 Sale : show line 5 in the form −3,700 $33.71 $124,727 69,360 D
2021-10-21 Exercise or conversion : show line 6 in the form +3,700 $6.55 $24,235 73,060 D
2021-10-21 Sale : show line 7 in the form −3,700 $33.73 $124,801 69,360 D
Open-market sales · 11,200 sh · avg $33.71 · $377,561

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-10-19 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −3,800 296,200 D
2021-10-20 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −3,700 292,500 D
2021-10-21 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −3,700 288,800 D
Loading xslF345X03/doc4.xml…